
The FDA approved adrabetadex for infantile-onset NPC based on a 55% lower risk of death vs external controls, with a boxed warning for hearing loss.
Closing the gaps in child-restraint laws, Cause of death: SIDS, or murder? When children kill, Babies First campaign. Eye on Washington






